![]() |
||||||||||||||||||||||||||||||||||||||||||||||||||
STI Surveillance: Annual Report 2002 |
Tuesday 7th September 2010 |
|||||||||||||||||||||||||||||||||||||||||||||||||
|
|
Contents
Chlamydia infections (the most
common bacterial STI in New Zealand) are still increasing and may soon
overtake genital warts as the most common infection in SHC patients.Notifications of C trachomatis by participating laboratories increased during 2002 to 10,307 cases representing a rate of 598 per 100 000 population which is five times higher than that reported in Australia during the same period. Similarly, rates of N gonorrhoeae, at 54 per 100,000 population almost doubles that of Australia. Groups at higher risk, by STI, are: Chlamydia: Maori and Pacific peoples Young people aged <25 Gonorrhoea: Maori and Pacific peoples Males aged <25 Genital herpes: Maori and Europeans All age-groups Genital warts: Europeans and Maori Young people aged <25 Syphilis: Pacific peoples Males and females >35 Cautionary note: This report summarises the epidemiology of STIs, using data from SHCs, FPCs, SYHCs and diagnostic laboratories in New Zealand. The figures presented here may underestimate true infection rates because not all clinics and laboratories participate and STIs diagnosed by a range of other health care providers, such as GPs, are not included in this report. It is also important to note the denominator used in calculating disease rates. Rates based on clinic data use the total number of clinic visits, whether for STIs or other conditions, as the denominator. Rates based on laboratory data use the total ‘usually resident’ population, in the District Health Boards covered by laboratory surveillance, from the 2001 New Zealand Census. Note: Click on the document links below to open. These documents are in PDF format. You will need to download the free Adobe Acrobat Reader to view them.
|
|
||||||||||||||||||||||||||||||||||||||||||||||||